Working within the Ontario Institute for Cancer Research/Cancer Care Ontario Health Services Research Program, and based in the Queen’s Cancer Research Institute (QCRI) Division of Cancer Care and Epidemiology (CCE), Dr. Timothy Hanna’s research focuses on three translational streams of health services research: quality of care, value of care and access to care.
As a cancer health services researcher, Hanna’s findings help identify ways to improve population health by driving improvements in cancer care delivery. His goal is to translate cutting-edge knowledge from clinical trials into widely adopted, accessible and high-quality interventions available to all Ontarians who need them.
Hanna’s vision is to develop the means to improve cancer care delivery so patients in Ontario and beyond will live longer and without cancer. They will have better symptom control, survivorship and quality of life. This will translate not only into benefits to patients with cancer, but also their families and society, provincially, nationally and globally.
- PhD, Health Services Research, University of New South Wales, Sydney, Australia
- Radiation Oncology Fellow, Collaboration for Cancer Outcomes Research and Evaluation, Liverpool Hospital, Sydney, New South Wales, Australia
- M.Sc., Epidemiology, Queen’s University
- Fellow, Health Services and Policy Research, Canadian Institutes of Health Research, Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute
- MD, Faculty of Medicine, University of Toronto
- Resident, Radiation Oncology, Kingston General Hospital, Cancer Centre of Southeastern Ontario
- Clinician Scientist I, OICR
- Faculty, Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute
- Radiation Oncologist and Clinician Scientist, Cancer Centre of Southeastern Ontario
- Adjunct Scientist, Institute for Clinical Evaluative Sciences, Cancer Research Program
- Assistant Professor, Radiation Oncology, Department of Oncology, Queen’s University
- Hanna TP, Chauvin C, Miao Q, …, Nanji S. Clinical Outcomes After Pulmonary Metastasectomy for Melanoma: A Population-Based Study. Ann Thorac Surg. 2018; In press.
- Hanna TP, Nguyen P, Baetz T, …, Eisenhauer E. A Population-based Study of Survival Impact of New Targeted and Immune-based Therapies for Metastatic or Unresectable Melanoma. Clin Oncol (R Coll Radiol). 2018; 30(10):609-617.
- Hanna TP, Shafiq J, Delaney GP, …, Barton MB. The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits. Radiother Oncol. 2018; 126(2):191-197.
- Hanna TP, Shafiq J, Delaney GP, Barton MB. The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiation. Radiother Oncol. 2015;114(3):389-94.
- Atun R, Jaffray DA, Barton MB, …, Hanna TP, …, Gospodarowicz M. Expanding global access to radiotherapy. Lancet Oncol. 2015;16(10):1153-86.
- Quality: Measure and improve access to quality care for melanoma patients in Ontario
- Value: Measure and define value for critical topics in radiotherapy and systemic therapy
A newly developed population database for melanoma with stage information provides additional opportunities to investigate health services research questions using provincial administrative data sources.
Visit OICR’s Collaborative Research Resources directory for more opportunities to collaborate with OICR researchers.